Largactil Liquid
fda sheet

Largactil Liquid
msds (material safety sheet)

Largactil Liquid
Synthesis Reference

Largactil Liquid
Molecular Weight

Largactil Liquid
Melting Point

< 25 oC

Largactil Liquid
H2O Solubility

2.55 mg/L

Largactil Liquid
State

Liquid

Largactil Liquid
LogP

5.512

Largactil Liquid
Dosage Forms

Drops; Liquid; Solution; Syrup; Tablet

Largactil Liquid
Indication

For the treatment of schizophrenia, control nausea and vomiting, For relief of restlessness and apprehension before surgery, adjunct in the treatment of tetanus, control the manifestations of the manic type of manic-depressive illness.

Largactil Liquid
Pharmacology

Chlorpromazine is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Chlorpromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Chlorpromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.